Found: 1
Select item for more details and to access through your institution.
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 655, p. 1, doi. 10.1126/scitranslmed.abn3715
- By:
- Publication type:
- Article